2-Aminobenzimidazole structure
|
Common Name | 2-Aminobenzimidazole | ||
|---|---|---|---|---|
| CAS Number | 934-32-7 | Molecular Weight | 133.151 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 368.9±25.0 °C at 760 mmHg | |
| Molecular Formula | C7H7N3 | Melting Point | 226-230 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 204.6±10.4 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | 2-aminobenzimidazole |
|---|---|
| Synonym | More Synonyms |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 368.9±25.0 °C at 760 mmHg |
| Melting Point | 226-230 °C(lit.) |
| Molecular Formula | C7H7N3 |
| Molecular Weight | 133.151 |
| Flash Point | 204.6±10.4 °C |
| Exact Mass | 133.063995 |
| PSA | 54.70000 |
| LogP | 0.78 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.780 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H317-H319-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R22;R36/37/38 |
| Safety Phrases | S26-S36/37/39-S22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | DD5775000 |
| HS Code | 29339990 |
| Precursor 10 | |
|---|---|
| DownStream 10 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Aggregation of 2-aminobenzimidazole--a combined experimental and theoretical investigation.
ChemPhysChem 12(9) , 1747-55, (2011) An investigation of 2-aminobenzimidazole was carried out by calculations at HF, MP2, and DFT levels of theory and also by UV and IR spectroscopy. The quantum chemical calculations predict a full shift... |
|
|
Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.
Bioorg. Med. Chem. Lett. 19(15) , 4380-4, (2009) The benzimidazole core of the selective non-brain-penetrating H(1)-antihistamine mizolastine was used to identify a series of brain-penetrating H(1)-antihistamines for the potential treatment of insom... |
|
|
Chemical biology strategy reveals pathway-selective inhibitor of NF-kappaB activation induced by protein kinase C.
ACS Chem. Biol. 5 , 287-299, (2010) Dysregulation of NF-kappaB activity contributes to many autoimmune and inflammatory diseases. At least nine pathways for NF-kappaB activation have been identified, most of which converge on the Ikappa... |
| usafek-4037 |
| 2H-Benzimidazol-2-imine, 1,3-dihydro- |
| 2-aMinobenziMidazde |
| 2-BENZIMIDAZOLAMINE |
| 1,3-Dihydro-2H-benzimidazol-2-imine |
| UNII-E65DE7521V |
| 2-amino-1H-benzimidazole |
| MFCD00005596 |
| 2-amino-benzimidazol |
| 2-Aminobenzimidazole |
| EINECS 213-280-6 |
| 2-amino-benzimidazole |
| BenziMidazoloniMide |
| 1H-Benzimidazol-2-amine |
| benzimidazole-amine |
| 2-BENZIMIDAZOLYLAMINE |
| AMINO-2-BENZIMIDAZOLE |
| 2-Iminobenzimidazoline |
| Rabeprazole Impurity 19 |